跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,474 条关于
“SYNC-T Therapy SV-102”
全部
96,474
临床试验
64,334
药物
11,152
机构
229
资讯
20,759
10个月前
Syncromune's SYNC-T Therapy Shows Bone Metastases Resolution in Phase 1 Prostate Cancer Trial
4个月前
Syncromune's SYNC-T Therapy Shows 87% Response Rate in Metastatic Prostate Cancer Phase 1 Trial
去年
Syncromune to Present Phase 1 Data on Novel SYNC-T Therapy for Metastatic Prostate Cancer at ASCO 2025
去年
SYNC-T SV-102 Shows Promising Response in Metastatic Castration-Resistant Prostate Cancer
9个月前
SYNC-T Therapy Shows 54% Complete Bone Metastasis Resolution in Phase 1 Prostate Cancer Trial
去年
Theratechnologies Awaits FDA Decision on EGRIFTA SV® Manufacturing Change
9个月前
Abpro and Celltrion Submit IND Application for HER2-Targeting T Cell Engager ABP-102/CT-P72
去年
Abpro and Celltrion's ABP-102/CT-P72 Shows Promise as Best-in-Class HER2 T-Cell Engager
去年
FDA Approves Theratechnologies' EGRIFTA SV Prior Approval Supplement and Alpha Tau's Trial for Recurrent Glioblastoma
去年
FDA Advisory Committee Rejects UroGen's Bladder Cancer Therapy UGN-102
第 1 页,共 2076 页
上一页
下一页